Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

23 Jun 2021 14:42

RNS Number : 8862C
Savills PLC
23 June 2021
 

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF PDMR

 

Grant of Share Award

 

The Company announces that on 22 June 2021 the grant of an award has been made under the Savills Deferred Share Plan to a person discharging managerial responsibilities ('PDMR') as follows:-

 

PDMR

Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on22 June 2021

Resulting beneficial interest under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan

Christian Mancini

89,525

112,690

25% of the above award has a Deferred Period of three years37.5% of the above award has a Deferred Period of four years37.5% of the above award has a Deferred Period of five years

The vesting of tranches with Deferred Periods of four and five years is subject to the satisfaction of performance criteria relating to the financial performance of Savills Asia Pacific ex-Greater China during 2021 to 2023.

All tranches of the award are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting dates to reflect final and interim dividends declared during the Deferred Periods.

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the PDMR

 

(a)

Name

Christian Mancini

 

2.

Reason for the notification

 

(a)

Position/ status

Chief Executive Officer - Asia Pacific (ex-Greater China)

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Grant of an award over Ordinary Shares in accordance with the Company's Deferred Share Plan

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

 

89,690

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

22 June 2021

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

23 June 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGZVFFMGMZM
Date   Source Headline
1st Oct 202511:00 amRNSTotal Voting Rights
29th Sep 202512:09 pmRNSDirector Declaration
25th Sep 20257:00 amRNSDirectorship Change
11th Sep 202512:38 pmRNSDirector/PDMR Shareholding
5th Sep 20252:00 pmRNSAdditional Listing
14th Aug 20257:00 amRNSHalf-year Report
12th Aug 20252:39 pmRNSDirector/PDMR Shareholding
1st Aug 20253:41 pmRNSHolding(s) in Company
21st Jul 20252:03 pmRNSBlock listing Interim Review
16th Jul 20251:44 pmRNSHolding(s) in Company
15th Jul 20254:20 pmRNSHolding(s) in Company
14th Jul 20251:14 pmRNSHolding(s) in Company
14th Jul 202510:18 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20255:20 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:45 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSAdditional Listing
12th Jun 20258:15 amRNSDirector/PDMR Shareholding
12th Jun 20258:10 amRNSDirector/PDMR Shareholding
10th Jun 20255:57 pmRNSDirector/PDMR Shareholding
4th Jun 202512:12 pmRNSHolding(s) in Company
2nd Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20258:58 amRNSHolding(s) in Company
22nd May 20255:31 pmRNSHolding(s) in Company
15th May 20254:06 pmRNSHolding(s) in Company
14th May 20252:38 pmRNSResult of AGM
14th May 20257:00 amRNSAGM Statement
13th May 20254:01 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSavills Announces Succession Plan
7th Apr 20254:18 pmRNSAnnual Report and AGM Notice
1st Apr 202511:00 amRNSTotal Voting Rights
24th Mar 20252:18 pmRNSHolding(s) in Company
21st Mar 20253:00 pmRNSAdditional Listing
20th Mar 20259:21 amRNSDirector/PDMR Shareholding
18th Mar 20252:27 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSFinal Results
12th Mar 202511:00 amRNSDirector/PDMR Shareholding
17th Feb 20254:43 pmRNSBlock listing Interim Review
12th Feb 202511:10 amRNSDirector/PDMR Shareholding
11th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 20253:51 pmRNSHolding(s) in Company
3rd Feb 202511:00 amRNSTotal Voting Rights
29th Jan 20252:28 pmRNSHolding(s) in Company
28th Jan 20253:47 pmRNSHolding(s) in Company
22nd Jan 202511:47 amRNSBlock listing Interim Review
16th Jan 20257:00 amRNSYear End Trading Update
13th Jan 20252:35 pmRNSDirector/PDMR Shareholding
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.